Back

Elevated cancer biomarkers in patients with severe heart failure could be a potential predictor of mortality during LVAD support

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Devices in heart failure: new findings Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Agnieszka Bielka

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

7 More presentations in this session

Presentation thumbnail
Predictors of Right vEntricular Failure aftER LVAD implantation: PREFER LVAD study
Associate Professor M. Cameli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Right ventricular failure following left ventricular assist device implantation.
Associate Professor M. Laimoud (Riyadh, SA)
Abstract Slides Video
Presentation thumbnail
Optimal anticoagulation strategy for left ventricular assist device patients undergoing thoracentesis: a retrospective study
Doctor S. Hegde (Charlotte, US)
Abstract Slides Video
Presentation thumbnail
A meta-analysis of the efficacy and safety of exercise-based cardiac rehabilitation in patients with left ventricular assist devices.
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Impact of digoxin on gastrointestinal bleeding following left ventricular assist device implantation: a systematic review and meta-analysis
Doctor H. Alani (Doha, QA)
Abstract Slides Video

Access the full session

Session thumbnail
Devices in heart failure: new findings

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Associations of heart failure biomarkers with cardiovascular and cancer mortality in cancer patients
thumbnail
Congress Presentation
Cancer and heart failure: mutual epidemiological and prognostic implications.
thumbnail
Congress Presentation
The reverse cardio-oncology perspective: the incidence of, and mortality from, cancer subsequent to a diagnosis of heart failure; an updated review and meta-analysis of observational studies.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources